Liquidia stock price target raised to $31 by Wells Fargo on strong launch

Published 13/08/2025, 11:08
Liquidia stock price target raised to $31 by Wells Fargo on strong launch

Investing.com - Wells Fargo raised its price target on Liquidia Technologies (NASDAQ:LQDA) to $31.00 from $25.00 on Wednesday, while maintaining an Overweight rating on the stock. The company’s stock has shown remarkable momentum, gaining over 80% in the past year and currently trading near its 52-week high of $24.83.

The price target increase follows Liquidia’s recent product launch performance that exceeded analyst expectations, with the company reporting 94 unique patient prescriptions per week and 57 patient starts per week.

Wells Fargo had previously anticipated approximately 15% upside on a positive update, but noted that the actual results surpassed their projections.

Prior to the recent stock appreciation, Wells Fargo believed the fundamental benchmark for Liquidia’s update was 80 prescriptions per month, which would align with management’s goal of achieving profitability within four quarters after launch.

The firm compared elements of Liquidia’s launch to those of VRNA and BBIO, suggesting the stock could continue to gain value despite what Wells Fargo described as "a high degree of skepticism" among investors regarding the launch.

In other recent news, Liquidia Technologies Inc . reported its second-quarter earnings for 2025, showcasing a remarkable revenue increase. The company achieved $8.8 million in revenue, significantly exceeding the anticipated $3.92 million. This surge was largely attributed to robust sales of its Eutropia product. However, Liquidia posted a larger-than-expected loss per share of $0.49, compared to the forecasted $0.42. Despite this, the market responded favorably to the revenue beat. Analysts have noted the impressive revenue performance, although specific upgrades or downgrades were not mentioned. These developments highlight the company’s financial activities and market reception in recent times.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.